Diego A. Díaz García/X
Jun 30, 2025, 06:57
Diego A. Díaz García Reflects on Nature Study Highlighting Challenges in Targeting Tumor-Infiltrating Tregs
Diego A. Díaz García, Medical Oncologist / CEO / Founder at CánCare – Advanced Specialty in Oncology, shared on X about a recent paper shared by Charlotte J. Imianowski et al. published in Nature:
“Tumor-infiltrating Tregs: powerful allies of cancer.
Targeting them is promising, but tricky.
They share biology with CD4+ T cells, and systemic depletion risks immune toxicity.We need smarter strategies to selectively disrupt them in the TME.”
Title: Regulatory T cells in the tumour microenvironment
Authors: Charlotte J. Imianowski, Qiang Chen, Creg J. Workman and Dario A. A. Vignali
Other posts featuring Diego A. Díaz García.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 19, 2025, 20:21
Jul 19, 2025, 20:00
Jul 19, 2025, 19:47
Jul 19, 2025, 19:13